stella
beta
Comparing a 6-month vs Long-term Course of Rezvilutamide With ADT Plus Chemotherapy in mHSPC — Stella
Recruiting
Back to Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Urology dpt, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu
View full record on ClinicalTrials.gov